Secondary aims were to investigate and compare the effects of liraglutide 1.8 and 3.0 mg on glucose metabolism, appetite sensations, energy intake, energy expenditure (EE) and substrate oxidation rates, and to explore the potential mechanisms for liraglutide-induced weight loss in obese individuals without T2DM
What happens when people stop taking GLP-1 drugs
Mol Metab (2019) 30:72130
GLP-1 microdosing may represent part of this evolution, offering a more nuanced approach to metabolic health optimization
These effects typically emerge during dose escalation and often diminish over several weeks as physiologic adaptation occurs
Behind the scenes, they operate under different structures, responsibilities, and regulatory How Do Online GLP-1 Programs Compare To In-Person Weight-Loss Care